This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jan;11(1):6-7.

doi: 10.1016/S1470-2045(09)70347-X. Epub 2009 Dec 10.

First-generation genomic tests for breast cancer treatment

Fabrice Andre, Suzette Delaloge

PMID: 20005177
DOI: 10.1016/S1470-2045(09)70347-X

Comment

First-generation genomic tests for breast cancer treatment

Fabrice Andre et al. Lancet Oncol. 2010 Jan.

. 2010 Jan;11(1):6-7.

doi: 10.1016/S1470-2045(09)70347-X. Epub 2009 Dec 10.

Authors

Fabrice Andre, Suzette Delaloge

PMID: 20005177
DOI: 10.1016/S1470-2045(09)70347-X

No abstract available

PubMed Disclaimer

Comment on

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR, Yoshizawa C, Allred DC, Osborne CK, Hayes DF; Breast Cancer Intergroup of North America. Albain KS, et al. Lancet Oncol. 2010 Jan;11(1):55-65. doi: 10.1016/S1470-2045(09)70314-6. Epub 2009 Dec 10. Lancet Oncol. 2010. PMID: 20005174 Free PMC article.

Similar articles

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR, Yoshizawa C, Allred DC, Osborne CK, Hayes DF; Breast Cancer Intergroup of North America. Albain KS, et al. Lancet Oncol. 2010 Jan;11(1):55-65. doi: 10.1016/S1470-2045(09)70314-6. Epub 2009 Dec 10. Lancet Oncol. 2010. PMID: 20005174 Free PMC article.
Translation, please.
Bleiweiss IJ, Raptis G. Bleiweiss IJ, et al. Lancet Oncol. 2007 Dec;8(12):1044-1045. doi: 10.1016/S1470-2045(07)70349-2. Lancet Oncol. 2007. PMID: 18054869 No abstract available.
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Lee KH, et al. BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63. BMC Cancer. 2007. PMID: 17430582 Free PMC article.
Current status of prognostic profiling in breast cancer.
Pusztai L. Pusztai L. Oncologist. 2008 Apr;13(4):350-60. doi: 10.1634/theoncologist.2007-0216. Oncologist. 2008. PMID: 18448548 Review.
[Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Petit T, Claude L, Carrie C. Petit T, et al. Cancer Radiother. 2004 Feb;8(1):54-8. doi: 10.1016/j.canrad.2003.10.006. Cancer Radiother. 2004. PMID: 15093202 Review. French.

See all similar articles

Cited by

Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients.
Mallmann MR, Staratschek-Jox A, Rudlowski C, Braun M, Gaarz A, Wolfgarten M, Kuhn W, Schultze JL. Mallmann MR, et al. EPMA J. 2010 Sep;1(3):421-37. doi: 10.1007/s13167-010-0044-z. Epub 2010 Aug 20. EPMA J. 2010. PMID: 23199086 Free PMC article.
Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast Cancer.
Farr A, Wuerstlein R, Heiduschka A, Singer CF, Harbeck N. Farr A, et al. Rev Obstet Gynecol. 2013;6(3-4):165-73. Rev Obstet Gynecol. 2013. PMID: 24920978 Free PMC article.
Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.
Ferté C, André F, Soria JC. Ferté C, et al. Nat Rev Clin Oncol. 2010 Jul;7(7):367-80. doi: 10.1038/nrclinonc.2010.84. Epub 2010 Jun 15. Nat Rev Clin Oncol. 2010. PMID: 20551944 Review.
Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.
Banerji CR, Severini S, Caldas C, Teschendorff AE. Banerji CR, et al. PLoS Comput Biol. 2015 Mar 20;11(3):e1004115. doi: 10.1371/journal.pcbi.1004115. eCollection 2015 Mar. PLoS Comput Biol. 2015. PMID: 25793737 Free PMC article.
Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples.
Elloumi F, Hu Z, Li Y, Parker JS, Gulley ML, Amos KD, Troester MA. Elloumi F, et al. BMC Med Genomics. 2011 Jun 30;4:54. doi: 10.1186/1755-8794-4-54. BMC Med Genomics. 2011. PMID: 21718502 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information